Advertisement

Rheologica: Pentoxifyllin

  • Hans Christian Korting
Chapter
  • 22 Downloads

Zusammenfassung

Viele, darunter häufige Hautkrankheiten speziell an den Extremitäten und hier speziell wiederum an den unteren Extremitäten stehen im Zusammenhang mit arteriellen und venösen Durchblutungsstörungen. Hierbei kann es hilfreich sein, die Durchblutung zu verbessern, insbesondere über eine Beeinflussung der Fließeigenschaften des Blutes. Besonders gut charakterisiert ist die Wirkung von Pentoxifyllin.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Monographien

  1. Arndt KA (1989) Manual of dermatological therapeutics, 4th edn. Little, Brown and Co., BostonGoogle Scholar
  2. Baran R, Barth J, Dawber R (Haneke E Hrsg. d. dt. Ausg.) (1993) Krankheiten der Nägel. Deutscher Ärzte-Verlag, Köln.Google Scholar
  3. Bartlett JG (1991) Pocketbook of infectious disease therapy. Williams & Wilkins, BaltimoreGoogle Scholar
  4. Bauer R, Gollnick H (Hrsg) ( 1984 ) Der Stellenwert der Retinoide in der Dermatologie. Grosse, BerlinGoogle Scholar
  5. Braun-Falco O, Plewig G, Wolff HH (1984) Dermatologie und Venerologie, 3. neubearb. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  6. Bundesverband der Pharmazeutischen Industrie (Hrsg) Rote Liste 1994. Editio Cantor, AulendorfGoogle Scholar
  7. Cunliffe WJ, Miller AJ (eds) (1984) Retinoid therapy. MTP Press, LancasterGoogle Scholar
  8. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (1993) Dermatology in general medicine, Vol. I and II, 4th ed. McGraw-Hill, New YorkGoogle Scholar
  9. Forth W, Henschler D, Rummel W (Hrsg) (1987) Allgemeine und spezielle Pharmakologie und Toxikologie, 5. Aufl. BI Wissenschaftsverlag, MannheimGoogle Scholar
  10. Gilman AG, Rall TW, Nies AS, Taylor P (eds) (1990) Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 8th Edition. Pergamon Press, New YorkGoogle Scholar
  11. Hurwitz S (1993) Clinical pediatric dermatology, 2nd. ed. Saunders, PhiladelphiaGoogle Scholar
  12. Kaiser H (1986) Praxis der Cortisontherapie, 2. Aufl. Urban & Schwarzenberg, MünchenGoogle Scholar
  13. Korting GW, Frank P (1987) Diagnose und Therapie der Hautkrankheiten. Schattauer, StuttgartGoogle Scholar
  14. Korting HC (1987) Cephalosporin-Therapie der Gonorrhoe. Karger, BaselGoogle Scholar
  15. Korting HC, Schäfer-Korting M, Mutschler E (1985) Pharmakokinetik oraler Antimykotika. Schattauer, StuttgartGoogle Scholar
  16. Maddin S (1991) Current dermatologic therapy, 2nd edn. Saunders, PhiladelphiaGoogle Scholar
  17. Mahrle G, Ippen H (Hrsg) (1985) Dermatologische Therapie. Beiträge zur Dermatologie, Bd 11. Perimed, ErlangenGoogle Scholar
  18. McCarthy DJ, Montgomery R (eds) (1986) Podiatric dermatology. Williams & Wilkins, BaltimoreGoogle Scholar
  19. Merk HF, Bickers DR (1992) Dermatopharmakologie und Dermatotherapie. Blackwell, BerlinGoogle Scholar
  20. Mier PD, van de Kerkhof PCM (eds) (1986) Textbook of psoriasis. Churchill Livingstone, EdinburghGoogle Scholar
  21. Mukthar H (ed) (1992) Pharmacology of the skin. CRC Press, Boca RatonGoogle Scholar
  22. Mutschler E (1991) Arzneimittelwirkungen, 6. Aufl. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  23. Newcomer VD, Young jr EM (1989) Geriatrie dermatology. Igaku-Shoin, New York, TokyoGoogle Scholar
  24. Plewig G, Kligman AM (1994) Akne und Rosazea, 2. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  25. Riecker C (Hrsg) (1991) Therapie innerer Krankheiten. Springer, HeidelbergGoogle Scholar
  26. Roenigk jr HH, Maibach HI (eds) (1991) Psoriasis, 2nd ed. Marcel Dekker, New YorkGoogle Scholar
  27. Ruzicka T, Ring J, Przybilla B (eds) (1991) Handbook of atopic eczema. Spinger, Berlin Heidelberg New YorkGoogle Scholar
  28. Saurat JH (ed) (1984) Retinoids: new trends in research and therapy. Karger, BaselGoogle Scholar
  29. Shelley WB, Shelley ED (1987) Advanced dermatologic therapy. Saunders, PhiladelphiaGoogle Scholar
  30. Simon C, Stille W, Wilkinson PJ (1993) Antibiotic therapy in clinical practice. Schattauer, StuttgartGoogle Scholar
  31. Wolverton SE, Wilkin JK (eds) (1991) Systemic drugs for skin diseases. Saunders, PhiladelphiaGoogle Scholar

Einzelarbeiten

  1. Abeck D, Korting HC (1991) Einsatz von Antibiotika bei Hauterkrankungen. Bayer Internist 2: 45–53Google Scholar
  2. Ad hoc Committee on the Use of Antibiotics in Dermatology (1975) Systemic antibiotics for treatment of acne vulgaris: efficacy and safety. Arch Dermatol 111: 1630Google Scholar
  3. Ahmed AR, Hombal SM (1984) Cyclophosphamide. J Am Acad Dermatol 11: 1115–1126PubMedGoogle Scholar
  4. Ahmed AR, Moy R (1981) Azathioprine. Int J Dermatol 20: 461–467Google Scholar
  5. Aram H (1987) Cimetidine in dermatology. Int J Dermatol 26: 161–166PubMedGoogle Scholar
  6. Arndt KA (1988) Adverse reactions to acyclovir: topical, oral and intravenous. J Am Acad Dermatol 18: 188–190PubMedGoogle Scholar
  7. Baciewicz AM, Baciewicz FA (1989) Cyclosporine pharmacokinetic drug interactions. Am J Surg 157: 264–271PubMedGoogle Scholar
  8. Ball AP (1986) Overview of clinical experience with ciprofloxacin. Eur J Clin Microbiol 5: 214–219PubMedGoogle Scholar
  9. Barraglough D (1986) The use of corticosteroid agents in connective tissue disorders. Med J Aust 144: 427–432Google Scholar
  10. Bickers DR (1983) Position paper — PUVA therapy. J Am Acad Dermatol 8: 265–270PubMedGoogle Scholar
  11. Biren CA, Barr RJ (1986) Dermatologic application of cyclosporin. Arch Dermatol 122: 1028–1032PubMedGoogle Scholar
  12. Boyd AS (1989) An overview of the retinoids. Am J Med 86: 568–574PubMedGoogle Scholar
  13. Clissold SP, Sorkin EM, Goa KL (1989) Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 37: 42–57PubMedGoogle Scholar
  14. Crowe S, Mills J (1988) The future of antiviral therapy. Dermatol Clin 6: 521–537PubMedGoogle Scholar
  15. Dantzig PJ (1974) Immunosuppressive and cytotoxic drugs in dermatology. Arch Dermatol 110: 393–406PubMedGoogle Scholar
  16. David M (1988) Adverse effects of retinoids. Med Toxicol 3: 273–288Google Scholar
  17. Dicken CH (1984) Retinoids: a review. J Am Acad Dermatol 11: 541–552PubMedGoogle Scholar
  18. Diller G, Orfanos CE (1982) Sind H2-Antagonisten in der Dermatologie nützlich? Hautarzt 33: 353–354PubMedGoogle Scholar
  19. Dorsky DI, Crumpacker CS (1987) Drugs five years later: acyclovir. Ann Intern Med 107: 859–874PubMedGoogle Scholar
  20. Drouin MA (1985) H1 antihistamines: perspective on the use of the conventional and new agents. Ann Allergy 55: 747–752PubMedGoogle Scholar
  21. Eady EA (1982) The use of antibiotics in acne therapy: oral or topical administration. J Antimicrob Chemother 10: 89–115PubMedGoogle Scholar
  22. Ellis CN, Voorhees JJ (1987) Etretinate therapy. J Am Acad Dermatol 16: 267–291PubMedGoogle Scholar
  23. Ely H (1988) Pentoxifylline in therapy in dermatology. Dermatol Clin 6: 585–608PubMedGoogle Scholar
  24. Eng RHK (1984) New antibiotics: new hopes and new problems. Int J Dermatol 23: 153–165PubMedGoogle Scholar
  25. Eron LJ (1987) Therapy of skin and skin structure infections with ciprofloxacin: an overview. Am J Med 82 (Suppl 4A): 224–226Google Scholar
  26. Fauci A (1976) Glucocorticoid therapy: mechanisms of action and clinical considerations. Ann Intern Med 84: 304–315PubMedGoogle Scholar
  27. Feingold DS, Wagner RF (1986) Antibacterial therapy ( CME article ). J Am Acad Dermatol 14: 535–548PubMedGoogle Scholar
  28. Fisher AA (1980) The antihistamines — clinical review. J Am Acad Dermatol 3: 303–306PubMedGoogle Scholar
  29. Fleischer AB Jr, Resnick SD (1989) The effect of antibiotics on the efficacy of oral contraceptives: a controversy revisited. Arch Dermatol 125: 1562–1564PubMedGoogle Scholar
  30. Flowers FP, Araujo OE, Nieves CH (1986) Antihistamines. Int J Dermatol 25: 224–231PubMedGoogle Scholar
  31. Fritsch PO (1981) Oral retinoids in dermatology (review). Int J Dermatol 20: 314–329PubMedGoogle Scholar
  32. Fritz K, Weston W (1984) Systemic glucocorticoid therapy of skin diseases in children. Pediatr Dermatol 1: 236–245PubMedGoogle Scholar
  33. Gallant C, Kenny P (1986) Oral glucocorticoisteroids and their complications. A review. J Am Acad Dermatol 14: 161–177PubMedGoogle Scholar
  34. Gendler E (1984) Azathioprine for use in dermatology. J Dermatol Surg Oncol 10: 462–464PubMedGoogle Scholar
  35. Ginsberg H, Rubenstein A, Brown WV (1986) Medical complications of isotretinoin. Clin Dermatol 4: 183–189PubMedGoogle Scholar
  36. Goodman DS (1984) Vitamin A and retinoids in health and disease. N Engl J Med 310: 1023–1031PubMedGoogle Scholar
  37. Greaves MW (1987) Pharmacology and significance of non-steroidal anti-inflammatory drugs in the treatment of skin diseases.J Am Acad Dermatol 16: 751–764PubMedGoogle Scholar
  38. Gupta AK, Anderson TF (1987) Psoralen photochemotherapy. J Am Acad Dermatol 17: 703–734PubMedGoogle Scholar
  39. Gupta AK, Brown MD, Ellis CN et al. (1989) Cyclosporine in dermatology. J Am Acad Dermatol 21: 1245–1256PubMedGoogle Scholar
  40. Hammerstein J, Meckies J, Rossberg LI et al. (1975) Use of cyproterone acetate ( CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 6: 827–836PubMedGoogle Scholar
  41. Inman HW, Vessey MP, Weslerholm B et al. (1970) Thromboembolic disease and the steroidal content of oral contraceptives: a report to the Committee on the Safety of Drugs. Br Med J 2: 203–209PubMedGoogle Scholar
  42. Jones HE (1982) Therapy of superficial fungal infections. Med Clin North Am 66: 873–893PubMedGoogle Scholar
  43. Kahan BD (1989) Drug therapy: cyclosporine. N Engl J Med 321: 1725–1738PubMedGoogle Scholar
  44. Korting HC, Schäfer-Korting M (1992) Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin. Arch Dermatol 128: 243–248PubMedGoogle Scholar
  45. Lesher JL Jr, Smith JG Jr (1987) Antifungal agents in dermatology. J Am Acad Dermatol 17: 383–394PubMedGoogle Scholar
  46. Lester RS (1989a) Corticosteroids. Clin Dermatol 7: 80–97Google Scholar
  47. Lester RS (1989b) Methotrexate. Clin Dermatol 7: 128–135Google Scholar
  48. Leyden JJ (1988) Retinoids and acne. J Am Acad Dermatol 19: 164–168PubMedGoogle Scholar
  49. Lowe NJ, David M (1988) New retinoids for dermatologic diseases. Dermatol Clin 6: 539–552PubMedGoogle Scholar
  50. McDonald CJ (1985) Cytotoxic agents for use in dermatology. J Am Acad Dermatol 12: 753–775PubMedGoogle Scholar
  51. McDonald CJ (1985) Use of cytotoxic drugs in dermatologic diseases. J Am Acad Dermatol 12: 965–975PubMedGoogle Scholar
  52. McEvoy MT, Stern RS (1987) Psoralens and related compounds in the treatment of psoriasis. Pharmacol Ther 34: 75–97PubMedGoogle Scholar
  53. Modai J (1988) The clinical use of macrolides. J Antimicrob Chemother 22 (Suppl B): 145–153PubMedGoogle Scholar
  54. Monroe EW (1988) Chronic urticaria: review of nonsedating Hi antihistamines in treatment. J Am Acad Dermatol 19: 842–849PubMedGoogle Scholar
  55. Namer M (1988) Clinical applications of antiandrogens. J Steroid Biochem 31: 719–729PubMedGoogle Scholar
  56. Neu HC (1982) Antistaphylococcal penicillins. Med Clin North Am 66: 51–60PubMedGoogle Scholar
  57. O’Brien JJ, Campoli-Richards DM (1989) Acyclovir: an updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 37: 233–309PubMedGoogle Scholar
  58. Orfanos CE, Ehlert R, Gollnick H (1987) The retinoids. A review of their clinical pharmacology and therapeutic use. Drugs 34: 459–503PubMedGoogle Scholar
  59. Page EH, Wexler DM, Guenther LC (1986) Cyclosporin A. J Am Acad Dermatol 14: 785–791PubMedGoogle Scholar
  60. Paller AS (1985) Dermatologic use of methotrexate in children. Pediatr Dermatol 2: 238–243PubMedGoogle Scholar
  61. Parrish LC, Witowski JA, Snow R et al. (1986) Cephalosporins in cutaneous infection. Int J Dermatol 25: 258–265Google Scholar
  62. Pochi PE (1982) Oral retinoids in dermatology. Arch Dermatol 118: 57–61Google Scholar
  63. Pochi PE, Ceilley RI, Coskey RJ et al. (1988) Guidelines for prescibing isotretinoin ( Accutane) in the treatment of female acne patients of childbearing potential. J Am Acad Dermatol 19: 920PubMedGoogle Scholar
  64. Rasmussen JE (1989) Advances in nondietary management of children with atopic dermatitis. Pediatric Dermatol 6: 210–215Google Scholar
  65. Richards DM, Brogden RN, Heel RC (1984) Astemizole: a review of its pharmacodynamic properties and therapeutic efficacy. Drugs 28: 38–61PubMedGoogle Scholar
  66. Rippon JW (1986) A new era in antimycotic agents (editorial). Arch Dermatol 122: 299–302Google Scholar
  67. Roenigk HH, Auerbach R, Maibach HI et al. (1982) Methotrexate guidelines-revised. J Am Acad Dermatol 6: 145–155PubMedGoogle Scholar
  68. Roenigk HH, Auerbach R, Maibach HI et al. (1988) Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol 19: 145–156PubMedGoogle Scholar
  69. Schäfer-Korting, M (1993) Pharmacokinetic optimisation of oral antifungal therapy. Clin Pharmacokinet 25: 329–341PubMedGoogle Scholar
  70. Schein PS, Winokur SH (1975) Immunosuppressive and cytotoxic chemotherapy: long-term complications. Ann Intern Med 82: 84–95PubMedGoogle Scholar
  71. Schuller DE, Turkewitz D (1986) Adverse effects of antihistamines. Postgrad Med 79: 75–86PubMedGoogle Scholar
  72. Silverman AK, Ellis CN, Voorhees JJ (1987) Hypervitaminosis A: paradigm of retinoid side effects. J Am Acad Dermatol 15: 1027–1039Google Scholar
  73. Sorkin EM, Heel RC (1985) Terfenadine: a review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29: 34–56PubMedGoogle Scholar
  74. Stern RS (1989) When a uniquely effective drug is teratogenic: the case of isotretinoin. N Engl J Med 320: 1007–1009PubMedGoogle Scholar
  75. Shalita AR, Cunningham WJ, Leyden JJ et al. (1983) Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol 9: 629–638PubMedGoogle Scholar
  76. Storrs FJ (1979) Use and abuse of systemic corticoid therapy. J Am Acad Dermatol 1: 95–105PubMedGoogle Scholar
  77. Strauss JS, Cunningham WJ, Leyden JJ et al. (1988) Isotretinoin and teratogenicity. Am J Acad Dermatol 19: 353–354Google Scholar
  78. Teelmann K (1989) Toxicology and teratogenicity to date. Pharmacol Ther 40: 29–43PubMedGoogle Scholar
  79. Thiers B (1988) Dermatologie therapy in the 1980s. Dermatol Clin 6: 609–622PubMedGoogle Scholar
  80. Thiers B (1989) Antiretroviral therapy. J Am Acad Dermatol 21: 443–454PubMedGoogle Scholar
  81. Truhan AP, Ahmed AR (1989) Corticosteroids: a review with emphasis on complications of prolonged systemic therapy. Ann Allergy 62:Google Scholar
  82. Vahlquist A, Rollman O (1987) Clinical pharmacology of 3 generations of retinoids. Dermatologica 175 (Suppl 1): 20–27PubMedGoogle Scholar
  83. Vahlquist A, Torma H (1988) Retinoids and keratinization. Current concepts. Int J Dermatol 27: 81–95PubMedGoogle Scholar
  84. Van Tyle JHV (1984) Ketoconazole. Pharmacotherapy 4: 343–373PubMedGoogle Scholar
  85. Walker RC, Wright AJ (1987) The quinolones. Mayo Clin Proc 62: 1007–1012PubMedGoogle Scholar
  86. Weil EK, Rosenberg JM (1989) Antihistamine agents in the pipeline. Hosp Pharm 24: 864–865Google Scholar
  87. Wolff de FA, Thomas TV (1986) Clinical pharmacokinetics of methoxsalen and other psoralens. Clin Pharmacokinet 11: 62–75PubMedGoogle Scholar
  88. Woodward JK (1988) Pharmacology and toxicology of nonclassical antihistamines. Cutis 42: 5–9PubMedGoogle Scholar
  89. Yarchoan R, Mitsuya H, Broder S (1989) Clinical and basic advances in the antiretroviral therapy of human immunodeficiency virus infection: a review. Am J Med 87: 191–200PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Hans Christian Korting
    • 1
  1. 1.Dermatologische Klinik und Poliklinik Klinikum InnenstadtLudwig-Maximilians-UniversitätMünchenGermany

Personalised recommendations